May 6, 2013

ETView Medical, Ltd., and Mercury Medical, Inc., (Mercury), Execute Distribution Agreement

 

The agreement enables Mercury to exclusively market ETView's VivaSight™ platform in several US states, including Florida, Georgia, South Carolina, North Carolina, Virginia, Maryland, District of Columbia, Tennessee, Arkansas, Alabama, Mississippi, Louisiana, Texas and Oklahoma.


(May 6, 2013 Tel Aviv, Israel) ETView Medical Ltd. (TASE: ETVW) announced today that it has entered into an exclusive distribution agreement with Mercury Medical, Inc., (Mercury). The agreement enables Mercury to market ETView's VivaSight™ platform, combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability in several US states, including Florida, Georgia, South Carolina, North Carolina, Virginia, Maryland, District of Columbia, Tennessee, Arkansas, Alabama, Mississippi, Louisiana, Texas and Oklahoma for a period of 2 years. Other terms were not disclosed.

William Edelman, CEO of ETView Medical commented, “We are excited to add Mercury to our expanding distributor network.” Mr. Edelman continued, “VivaSight™ is currently being distributed across Europe, Asia and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation.”

On April 30 2013 ETView Medical, Ltd., announced US FDA Clearance of a 510(k) Pre-marketing Notification Application expanding the VivaSight™-DL line of innovative airway devices.

On March 18, 2013, ETView Medical, Ltd., announced State Food and Drug Administration (SFDA, China) Clearance of a Pre-marketing Notification Application for the VivaSight™-SL line of innovative airway devices.

About Mercury Medical, Inc.

According to information provided to the company, Mercury Medical, Inc., located in Clearwater, FL Mercury Medical is celebrating its 50th year as an internationally recognized specialty medical device manufacturer, marketing specialist and distributor specializing in quality airway management products and services sold worldwide. For 5 decades, Mercury has been transforming patient outcomes by providing state-of-the-art technologies and unique manufactured products including CPR Bags, disposable CPAP systems, disposable Infant T-Piece Resuscitators and CO2 detectors.

About ETView Medical, Ltd.

ETView Medical Ltd. (TASE: ETVW) has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView's patented VivaSight™  airway management portfolio consists of single-use disposable medical devices, representing either single or double lumen ventilation tubes with an integrated continuous high resolution airway imaging system. VivaSight™-SL and VivaSight™-DL are currently sold in Europe, Israel, and the US to overcome current limitations and associated adverse surgical events during lung isolation surgeries. Lung isolation is employed to provide one-lung ventilation in patients undergoing thoracic, cardiac, vascular, or esophageal surgeries.  During lung isolation, temporary visualization of the patent airway is achieved with a fiberoptic bronchoscope while the patient is ventilated and the target lung isolated. Intra-operative surgical maneuvers often require repeated imaging and partial blocking of the airway to maintain lung isolation.  It is estimated that over 1.9 million lung isolation procedures are conducted worldwide annually,  accounting for over $250mm in single-use medical disposables.  ETView has pioneered development of the VivaSight™ platform, combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability (eliminating the need for fiberoptic bronchoscope  imaging during these procedures).

Forward-Looking Statement

The Company estimations in this press release, including those estimations regarding the Company's predicted scope of business, constitute forward-looking statements, as such term is defined under the Israeli Securities Law (5728-1968), and there is no certainty that such estimations shall materialize. The Company's estimations are based on business assumptions, prior experience, and professional data. Due to various factors, foreseen and unforeseen, including, but not limited to, changes in market trends, competition, global or local economic conditions, and amendments of regulation, such estimations may not materialize in whole or in part, or materialize in a substantially different manner than anticipated by the Company.

  • Patents issued and pending
  • Principles and Practices of Anesthesia for 
       Thoracic Surgery. P. Singer (ed.) 2011
  • Anesthesia & Analgesia. 2009;108:1097–101
  • National Health Statistics Reports Number 29, October 26, 2010
  • Company estimates on file
  • Minerva Anestesiol. 2009;75(Suppl 1):1-4.